These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16092164)

  • 21. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
    Gaede KI; Amicosante M; Schürmann M; Fireman E; Saltini C; Müller-Quernheim J
    J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beryllium sensitivity is linked to HLA-DP genotype.
    Wang Z; Farris GM; Newman LS; Shou Y; Maier LA; Smith HN; Marrone BL
    Toxicology; 2001 Aug; 165(1):27-38. PubMed ID: 11551429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic susceptibility to beryllium: a case-referent study of men and women of working age with sarcoidosis or other chronic lung disease.
    Cherry N; Beach J; Burstyn I; Parboosingh J; Schouchen J; Senthilselvan A; Svenson L; Tamminga J; Yiannakoulias N
    Occup Environ Med; 2015 Jan; 72(1):21-7. PubMed ID: 25305207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of FCGR3A gene in chronic beryllium disease.
    Liu B; Maier LA; Hamzeh N; MacPhail K; Mroz MM; Liu H; Li L
    Genes Immun; 2019 Jul; 20(6):493-499. PubMed ID: 30245507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Ensey JS; Schuler CR; Kreiss K; Weston A
    Am J Ind Med; 2004 Aug; 46(2):95-103. PubMed ID: 15273960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beryllium sensitization and lung function among former workers at the Nevada Test Site.
    Rodrigues EG; McClean MD; Weinberg J; Pepper LD
    Am J Ind Med; 2008 Jul; 51(7):512-23. PubMed ID: 18459143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity.
    Rogliani P; Amicosante M; Berretta F; Dotti C; Bocchino M; O'Donnell KM; Saltini C
    Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):3-10. PubMed ID: 15345185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology of chronic beryllium disease.
    Samuel G; Maier LA
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):126-34. PubMed ID: 18317020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.
    Kreiss K; Fechter-Leggett ED; McCanlies EC; Schuler CR; Weston A
    J Occup Environ Med; 2016 Sep; 58(9):855-60. PubMed ID: 27414009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease.
    Silver K; Sharp RR
    J Occup Environ Med; 2006 Apr; 48(4):434-43. PubMed ID: 16607200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP; Maier LA
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
    Weston A; Snyder J; McCanlies EC; Schuler CR; Andrew ME; Kreiss K; Demchuk E
    Mutat Res; 2005 Dec; 592(1-2):68-78. PubMed ID: 16054169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent chronic beryllium disease in residents surrounding a beryllium facility: patients' information.
    Rossman MD
    Am J Respir Crit Care Med; 2009 Jan; 179(2):173. PubMed ID: 19119155
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between IL-1A single nucleotide polymorphisms and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Yucesoy B; Mnatsakanova A; Slaven JE; Andrew M; Frye BL; Schuler CR; Kreiss K; Weston A
    J Occup Environ Med; 2010 Jul; 52(7):680-4. PubMed ID: 20595916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic berylliosis].
    Müller-Quernheim J; Gaede KI; Prasse A; Zissel G
    Pneumologie; 2007 Feb; 61(2):109-16. PubMed ID: 17290317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of genetic and exposure factors in the prevalence of berylliosis.
    Richeldi L; Kreiss K; Mroz MM; Zhen B; Tartoni P; Saltini C
    Am J Ind Med; 1997 Oct; 32(4):337-40. PubMed ID: 9258386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beryllium exposure: dermal and immunological considerations.
    Day GA; Stefaniak AB; Weston A; Tinkle SS
    Int Arch Occup Environ Health; 2006 Feb; 79(2):161-4. PubMed ID: 16231190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis.
    Jonth AC; Silveira L; Fingerlin TE; Sato H; Luby JC; Welsh KI; Rose CS; Newman LS; du Bois RM; Maier LA;
    J Immunol; 2007 Sep; 179(6):4255-62. PubMed ID: 17785866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.